Pharmaceutical Litigation Attorneys

WE ARE NO LONGER ACCEPTING Granuflo or naturalyte CASES

GranuFlo and NaturaLyte are two brand names dialysates that are used during a dialysis treatment. Fresenius Medical Care manufactures both of these drugs, and both have been linked to serious cases of patient harm, including fatalities. Because there is evidence to suggest that Fresenius Medical Care knew of the potential harm associated with the use of GranuFlo and NaturaLyte, but continued to market the drug regardless without issuing a proper warning, the company may be held liable for all patient damages. A pharmaceutical litigation attorney can assist you in filing a claim.

The Risks of GranuFlo & NaturaLyte

The active ingredient in GranuFlo and NaturaLyte is sodium diacetate. When used during dialysis, a patient treated with GranuFlo and NaturaLyte receives more than the usual amount of bicarbonate than would be received using other brands of dialysates. This can be extremely dangerous; the biggest risk of excess bicarbonate is having a sudden, fatal heart attack. Other problems associated with excess bicarbonate as a result of using GranuFlo and NaturaLyte include:
  • Stroke;
  • Low blood pressure;
  • Low potassium;
  • Irregular heartbeat; and
  • High blood carbon dioxide.
 

Filing a Lawsuit Against Fresenius Medical Care

There are multiple lawsuits that have been filed against Fresenius Medical Care. These lawsuits allege that Fresenius knew of the risks of excess bicarbonate—as well as the related dangers—associated with the use of GranuFlo & NaturaLyte, and yet failed to disclose these dangers to the FDA or the public at large. If you or a loved one has been harmed as a result of dialysis treatment that utilized GranuFlo and NaturaLyte, you too may have a cause of action. A lawsuit can yield damages for medical expenses and other economic losses, pain and suffering, and wrongful death benefits if applicable.  

Contact a Defective Drug Attorney Now

If GranuFlo and NaturaLyte have harmed you, time is running out to file a lawsuit. To ensure that you retain your right to file a civil action, contact the experienced pharmaceutical litigation attorneys at Napoli Shkolnik, PLLC. With multiple law offices throughout the U.S., we represent clients in a variety of states. Call us today to schedule a consultation to learn more.
Andexanet Alfa (Andexxa) Withdrawn from U.S. Market: What Patients Need to Know

by Christopher R. LoPalo, Partner AstraZeneca has withdrawn Andexxa (andexanet alfa) from the United States market effective December 22, 2025. Patients who experienced adverse health outcomes, complications, or...

Read the Article
PFAS in Biosolids: 2025 Statehouses Take the Lead

For PFAS in biosolids, 2025 was the year statehouses stepped decisively into the vacuum. While federal policy is evolving, state and local governments are rapidly redrawing the rules...

Read the Article
Suspected Birth Injury? What Parents Need to Know and Do Next

Bringing a baby into the world is supposed to be joyful. When something goes wrong during pregnancy, labor, or delivery, that joy can be replaced in an instant...

Read the Article
Contact Us:
Get a Free Case Evaluation Attorney Referral
Settlements In This Area
See All Settlements

Our Locations

Please Contact Us for an In-Person Appointment